Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.1 million shares were traded. RMTI stock price reached its highest trading level at $1.2898 during the session, while it also had its lowest trading level at $1.19.
Ratios:
For a better understanding of RMTI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.19. For the most recent quarter (mrq), Quick Ratio is recorded 2.51 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.46 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On June 24, 2019, Piper Jaffray started tracking the stock assigning a Overweight rating and target price of $10.
On May 13, 2019, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on May 13, 2019, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when Chole Timothy sold 2,868 shares for $0.82 per share. The transaction valued at 2,352 led to the insider holds 128,167 shares of the business.
Neri Jesse sold 886 shares of RMTI for $727 on Jul 01 ’25. The SVP and CFO now owns 126,614 shares after completing the transaction at $0.82 per share. On Jul 01 ’25, another insider, Strobeck Mark, who serves as the President and CEO of the company, sold 6,926 shares for $0.82 each. As a result, the insider received 5,679 and left with 337,752 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMTI now has a Market Capitalization of 43382244 and an Enterprise Value of 38967244. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.49 while its Price-to-Book (P/B) ratio in mrq is 1.43. Its current Enterprise Value per Revenue stands at 0.443 whereas that against EBITDA is 43.49.
Stock Price History:
The Beta on a monthly basis for RMTI is 1.75, which has changed by -0.66578245 over the last 52 weeks, in comparison to a change of 0.15535986 over the same period for the S&P500. Over the past 52 weeks, RMTI has reached a high of $5.15, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is -0.45%, while the 200-Day Moving Average is calculated to be -11.00%.
Shares Statistics:
Over the past 3-months, RMTI traded about 1.37M shares per day on average, while over the past 10 days, RMTI traded about 1788130 shares per day. A total of 34.43M shares are outstanding, with a floating share count of 28.93M. Insiders hold about 15.97% of the company’s shares, while institutions hold 17.11% stake in the company. Shares short for RMTI as of 1756425600 were 1023721 with a Short Ratio of 0.75, compared to 1753920000 on 101698. Therefore, it implies a Short% of Shares Outstanding of 1023721 and a Short% of Float of 3.36.
Earnings Estimates
The dynamic stock of Rockwell Medical Inc (RMTI) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.17 and -$0.18 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.13, with 2.0 analysts recommending between -$0.09 and -$0.17.
Revenue Estimates
2 analysts predict $16.24M in revenue for. The current quarter. It ranges from a high estimate of $16.8M to a low estimate of $15.69M. As of. The current estimate, Rockwell Medical Inc’s year-ago sales were $28.32MFor the next quarter, 2 analysts are estimating revenue of $17.15M. There is a high estimate of $18.13M for the next quarter, whereas the lowest estimate is $16.17M.
A total of 2 analysts have provided revenue estimates for RMTI’s current fiscal year. The highest revenue estimate was $69.91M, while the lowest revenue estimate was $66.84M, resulting in an average revenue estimate of $68.37M. In the same quarter a year ago, actual revenue was $101.49MBased on 2 analysts’ estimates, the company’s revenue will be $75.89M in the next fiscal year. The high estimate is $81.59M and the low estimate is $70.18M.
